Clostridium difficile infection in hospitals: a brewing storm

Valiquette, Louis; Low, Donald E.; P├ępin, Jacques; McGeer, Allison
July 2004
CMAJ: Canadian Medical Association Journal;7/6/2004, Vol. 171 Issue 1, p27
Academic Journal
Discusses research being done on Clostridium difficile-associated diarrhea (CDAD). Reference to a study by L. Eggertson and B. Sibbald, published in the June 4, 2004 issue of the "Canadian Medical Association Journal"; Estimated incidence of CDAD in Canada; Factors contributing to the incidence of CDAD.


Related Articles

  • Fluoroquinolone Use and Clostridium difficile-associated Diarrhea. McCusker, Margaret E.; Harris, Anthony D.; Perencevich, Eli; Roghmann, Mary-Claire // Emerging Infectious Diseases;Jun2003, Vol. 9 Issue 6, p730 

    Focuses on a case-control study which evaluated the association between antibiotic use and Clostridium difficile-associated diarrhea (CDAD). Characteristics of CDAD cases and matched controls; Risks factors for CDAD; Association between fluoroquinolones and CDAD.

  • A Predictive Model to Identify Clostridium difficile Toxin in Hospitalized Patients with Diarrhea. Cooper, Gregory S.; Lederman, Michael M.; Salata, Robert A. // American Journal of Gastroenterology;Jan1996, Vol. 91 Issue 1, p80 

    Objectives: Although Clostridium difficile is a common pathogen in hospitalized patients with diarrhea, no study has attempted to develop a predictive model to estimate the likelihood of C. difficile positivity. Methods: We conducted a cross-sectional study at a single hospital...

  • Leukocytosis and Clostridium difficile-Associated Diarrhea. Bartlett, John G. // American Journal of Gastroenterology;Nov2000, Vol. 95 Issue 11, p3023 

    Provides information on leukocytosis and Clostridium difficile-associated diarrhea. Information on Clostridium difficile (C. difficile) testing; Ways that an antibiotic associated diarrhea laboratory finding can assist a practitioner; Use of hypoalbuminemia.

  • Clostridium difficile-associated diarrhoea (CDAD): new and contentious issues. GOULIOURIS, THEODOROS; FORSYTH, DUNCAN R.; BROWN, NICHOLAS M. // Age & Ageing;Sep2009, Vol. 38 Issue 5, p497 

    The article offers information on clostridium difficile-associated diarrhoea (CDAD). The current strategies for the prevention of the disease are discussed. Recent American and British treatment recommendation for CDAD emphasise the importance assessing the severity of the disease to stratify...

  • Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series. MACCONNACHIE, A. A.; FOX, R.; KENNEDY, D. R.; SEATON, R. A. // QJM: An International Journal of Medicine;Nov2009, Vol. 102 Issue 11, p781 

    Background: Clostridium difficile-associated diarrhoea (CDAD) is an increasingly common and life threatening consequence of modern medical practice. Recurrent disease is seen in up to one-third of patients and there is no consensus on optimal therapy. Restoration of normal colonic flora...

  • Who Gets C. difficile Diarrhea? Lee, Scott; Surawicz, Christina M.; Johnson, David // American Journal of Gastroenterology;Sep2000, Vol. 95 Issue 9, p2381 

    To test whether acquired antibody responses to C. difficile can protect against C. difficile toxin induced diarrhea, these researchers screened consecutive in-patients admitted to two general medical wards over a 5-month period. They collected stool samples for C....

  • Clostridium difficile Infection: What's New? Geom Seog Seo // Intestinal Research;2013, Vol. 11 Issue 1, p1 

    Since 2000, Clostridium difficile infection has increased substantially in both hospital-acquired and community-acquired diarrhea, not only in North America but also in Europe. There was a steady increase in the incidence and severity of C. difficile infection over the past decade, associated...

  • Successful Treatment of Fulminant Clostridium difficile Infection with Fecal Bacteriotherapy. You, David M.; Franzos, M. Alaric; Holman, Robert P. // Annals of Internal Medicine;4/15/2008, Vol. 148 Issue 8, p632 

    The article presents a study on fecal bacteriotherapy as a treatment to fulminant Clostridium difficile infection. The objective of the study is to determine a successful case of using fecal bacteriotherapy to treat life-threatening, fulminant C. difficile enterocolitis. Fecal bacteriotherapy is...

  • Intestinal Superbug Claims More Lives. Lockwood, Amy E. // Homeopathy Today;Apr2006, Vol. 26 Issue 2, p28 

    The article reports on the spread of Clostridium difficile (C-diff), a toxin-producing bacteria that is considered as one of the primary causes of diarrhea, colitis and death each year in the U.S. Medical experts had identified several contributory factors to the increased virulence of C-diff,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics